CervoMed Inc.
General ticker "CRVO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $157.6M (TTM average)
CervoMed Inc. follows the US Stock Market performance with the rate: 14.4%.
Estimated limits based on current volatility of 3.3%: low 7.66$, high 8.18$
Factors to consider:
- Total employees count: 8 as of 2023
Short-term CRVO quotes
Long-term CRVO plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $3.48MM | $7.81MM | $18.23MM |
| Operating Income | $-3.48MM | $-7.81MM | $-18.23MM |
| Non-Operating Income | $-2.33MM | $5.64MM | $1.94MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $1.34MM | $8.44MM | $18.80MM |
| Income(Loss) | $-5.80MM | $-2.17MM | $-16.29MM |
| Profit(Loss)* | $-5.80MM | $-2.17MM | $-16.29MM |
| Stockholders Equity | $-9.00MM | $7.38MM | $39.20MM |
| Assets | $4.16MM | $9.97MM | $43.08MM |
| Operating Cash Flow | $-2.57MM | $-7.45MM | $-16.53MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-28.66MM |
| Financing Cash Flow | $0.00MM | $11.15MM | $46.40MM |
| Earnings Per Share** | $-11.20 | $-0.82 | $-2.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.